IP Verse

Competitive analysis in Vaccines/Immunity Drugs industry

Latest patents granted in the Vaccines/immunity Drugs industry

Patent:
EP3218406
Grant Date:
Oct 2, 2024
Title:
Binding Molecules Specific For Cd73 And Uses Thereof
Applicant:
MEDIMMUNE LIMITED
Patent:
EP3506884
Grant Date:
Sep 25, 2024
Title:
Drug Delivery Compositions And Uses Thereof
Applicant:
DANA-FARBER CANCER INSTITUTE, INC.
Patent:
EP2676679
Grant Date:
Aug 28, 2024
Title:
Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic Compositions
Applicant:
WYETH LLC
Patent:
EP3152234
Grant Date:
Jun 26, 2024
Title:
Antibody Which Is Directed Against Galectin-9 And Is An Inhibitor Of The Suppressor Activity Of Regulatory T Lymphocytes
Applicant:
CELLVAX
Patent:
EP3296395
Grant Date:
Jun 19, 2024
Title:
Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Patent:
EP2099480
Grant Date:
Jun 12, 2024
Title:
Microorganisms Of Fractions Thereof Capable Of Activating Cellular Immunity Against Carbohydrates
Applicant:
GLYCOTOPE GMBH
Patent:
EP3167888
Grant Date:
May 1, 2024
Title:
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
Applicant:
ALEXION PHARMACEUTICALS, INC.
Patent:
EP3246044
Grant Date:
Apr 10, 2024
Title:
Stable Formulations Of Neisseria Meningitidis Rlp2086 Antigens
Applicant:
WYETH LLC
Patent:
EP3294770
Grant Date:
Mar 20, 2024
Title:
Therapeutic And Diagnostic Methods For Cancer
Applicant:
F. HOFFMANN-LA ROCHE AG
Patent:
EP2637670
Grant Date:
Mar 13, 2024
Title:
Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains
Applicant:
AMGEN RESEARCH (MUNICH) GMBH

Top patents facing oppositions in Vaccines/immunity Drugs industry

Patent:
EP3768304
Grant Date:
Oct 12, 2022
Title:
Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins
Applicant:
SPARK THERAPEUTICS, INC.
Oppositions:
36
Patent:
EP2397155
Grant Date:
Dec 13, 2017
Title:
Methods And Compositions For The Treatment Of Persistent Infections And Cancer By Inhibiting The Programmed Cell Death 1 (Pd-1)Pathway
Applicant:
EMORY UNIVERSITY
Oppositions:
36
Patent:
EP3261651
Grant Date:
May 4, 2022
Title:
Chimeric Antigen Receptors (Cars) Targeting Hematologic Malignancies, Compositions And Methods Of Use Thereof
Applicant:
MA, YUPO
Oppositions:
36
Patent:
EP2958588
Grant Date:
Aug 23, 2017
Title:
Combination Of Vaccination And Inhibition Of The Pd-1 Pathway
Applicant:
CUREVAC SE
Oppositions:
30
Patent:
EP3177645
Grant Date:
Feb 17, 2021
Title:
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer
Applicant:
LINDIS BIOTECH GMBH
Oppositions:
30
Patent:
EP3616720
Grant Date:
Feb 17, 2021
Title:
Pharmaceutical Composition For Cancer Treatment
Applicant:
SHIONOGI & CO., LTD
Oppositions:
30
Patent:
EP1968630
Grant Date:
Jan 24, 2018
Title:
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions
Applicant:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Oppositions:
30
Patent:
EP2992897
Grant Date:
Jul 4, 2018
Title:
Immunogenic Compositions Comprising Lawsonia Intercellularis
Applicant:
BOEHRINGER INGELHEIM VETMEDICA, INC.
Oppositions:
28
Patent:
EP3119423
Grant Date:
Dec 14, 2022
Title:
Treatment Of Cancer Using Chimeric Antigen Receptor
Applicant:
NOVARTIS AG
Oppositions:
24
Patent:
EP3292873
Grant Date:
May 1, 2019
Title:
Combination Of Vaccination And Inhibition Of The Pd-1 Pathway
Applicant:
CUREVAC AG
Oppositions:
24

Top companies filing oppositions in Vaccines/immunity Drugs industry

Company:
STRAWMAN LIMITED
Total oppositions filed:
52
Company:
PFIZER INC.
Total oppositions filed:
47
Company:
JAMES POOLE LIMITED
Total oppositions filed:
33
Company:
SANOFI
Total oppositions filed:
29
Company:
CEVA SANTE ANIMALE
Total oppositions filed:
27
Company:
BOEHRINGER INGELHEIM VETMEDICA GMBH
Total oppositions filed:
27
Company:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Total oppositions filed:
25
Company:
KONIG SZYNKA TILMANN VON RENESSE
Total oppositions filed:
24
Company:
REGENERON PHARMACEUTICALS, INC.
Total oppositions filed:
23
Company:
MAIWALD GMBH
Total oppositions filed:
20

Top companies facing oppositions in Vaccines/immunity Drugs industry

Company:
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Total facing oppositions:
75
Company:
BOEHRINGER INGELHEIM VETMEDICA, INC.
Total facing oppositions:
66
Company:
GLAXOSMITHKLINE BIOLOGICALS S.A.
Total facing oppositions:
64
Company:
NOVARTIS AG
Total facing oppositions:
61
Company:
GLAXOSMITHKLINE BIOLOGICALS SA
Total facing oppositions:
58
Company:
CUREVAC AG
Total facing oppositions:
57
Company:
CUREVAC SE
Total facing oppositions:
49
Company:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Total facing oppositions:
47
Company:
F. HOFFMANN-LA ROCHE AG
Total facing oppositions:
45
Company:
BRISTOL-MYERS SQUIBB COMPANY
Total facing oppositions:
39

Need more information?

Feel free to send us a message here and we will get back to you